[Equity, public health and genomics: the legal, social and biotechnology challenge in México]. / Equidad, salud pública y genómica: el reto jurídico, social y biotecnológico en México.
Gac Med Mex
; 149(5): 562-8, 2013.
Article
em Es
| MEDLINE
| ID: mdl-24108344
Mexico has entered an era where health research is enriched by the study of genetic variants that determinate how the different human populations are differentially susceptible to diseases. The objective is to design new strategies in health care and services based on medical genomics. However, to ensure universal access to these products, we should rethink the legal aspects that facilitate the design of health policies, based on the principle of equity. Intrinsic factors of the Mexican health system as inequity, poverty and low investment in health research, are challenges that add to the development of appropriate distribution strategies for the use of new genomic products for health. This article discusses these challenges and establish the basis to design policies and appropriate use of these new genomic-based health care services.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Biotecnologia
/
Saúde Pública
/
Genômica
Tipo de estudo:
Prognostic_studies
Aspecto:
Determinantes_sociais_saude
/
Equity_inequality
País/Região como assunto:
Mexico
Idioma:
Es
Revista:
Gac Med Mex
Ano de publicação:
2013
Tipo de documento:
Article
País de publicação:
México